Complete-PS
Brief summary
This was a Canadian post-marketing observational study (PMOS) utilizing a prospective cohort design that compared the real - life effectiveness of an active drug to topical and traditional systemic agents in the management of psoriasis and its impact on the patient's quality of life and societal burden of illness.
Observational study
Age:
18 Years and older.
Inclusion Criteria:
- Active moderate or severe plaque psoriasis according to the judgment of the treating
physician.
- The treating physician has decided to change the current treatment or add additional
treatments for any reason including but not limited to inadequate response,
intolerance, sub-optimal compliance or participant preference.
Exclusion Criteria:
- Had currently participated in another prospective study with similar objectives.
- Participant could not or would not sign informed consent.
- Presence of other condition that, in the opinion of the treating physician, prohibits
the participant from participating in the study or obscured the assessment of the
treatment of plaque psoriasis.
